These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 8810998)

  • 1. Human immunodeficiency virus grown in CD4-expressing cells is associated with CD4.
    Hartley CA; Gilbert MJ; Brigido L; Elbeik T; Levy JA; Crowe SM; Mills J
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2015-23. PubMed ID: 8810998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HSV-1-specific cytotoxic T lymphocytes by recombinant-derived gp120 of HIV-1.
    Schmid DS; Thieme ML; Ridgeway MR; Mawle AC
    Viral Immunol; 1992; 5(4):249-56. PubMed ID: 1361737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propagation of CD4+ T cells specific for HIV type 1 envelope gp120 from chronically HIV type 1-infected subjects.
    Cohen S; Tuen M; Hioe CE
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):793-806. PubMed ID: 14585210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The orientation of HIV-1 gp120 binding to the CD4 receptor differentially modulates CD4+ T cell activation.
    Zimmermann K; Liechti T; Haas A; Rehr M; Trkola A; Günthard HF; Oxenius A
    J Immunol; 2015 Jan; 194(2):637-49. PubMed ID: 25472996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
    Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS patient monocytes target CD4 T cells for cellular conjugate formation and deletion through the membrane expression of HIV-1 envelope molecules.
    Dudhane A; Wang ZQ; Orlikowsky T; Gupta A; Wormser GP; Horowitz H; Kufer P; Hoffmann MK
    AIDS Res Hum Retroviruses; 1996 Jul; 12(10):893-9. PubMed ID: 8798974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection.
    Briant L; Coudronnière N; Robert-Hebmann V; Benkirane M; Devaux C
    J Immunol; 1996 May; 156(10):3994-4004. PubMed ID: 8621941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
    Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
    Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lateral diffusion of CD4 on the surface of a human neoplastic T-cell line probed with a fluorescent derivative of the envelope glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV-1).
    Pal R; Nair BC; Hoke GM; Sarngadharan MG; Edidin M
    J Cell Physiol; 1991 May; 147(2):326-32. PubMed ID: 2040664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
    Konopka K; Pretzer E; Celada F; Düzgüneş N
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients.
    Wang ZQ; Orlikowsky T; Dudhane A; Mittler R; Blum M; Lacy E; Riethmüller G; Hoffmann MK
    Eur J Immunol; 1994 Jul; 24(7):1553-7. PubMed ID: 7913036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients.
    Amadori A; De Silvestro G; Zamarchi R; Veronese ML; Mazza MR; Schiavo G; Panozzo M; De Rossi A; Ometto L; Mous J
    J Immunol; 1992 May; 148(9):2709-16. PubMed ID: 1374095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential susceptibility to monomeric HIV gp120-mediated apoptosis in antigen-activated CD4+ T cell populations.
    Tuosto L; Gilardini Montani MS; Lorenzetti S; Cundari E; Moretti S; Lombardi G; Piccolella E
    Eur J Immunol; 1995 Oct; 25(10):2907-16. PubMed ID: 7589091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
    Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
    Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
    Bower JF; Green TD; Ross TM
    Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the basis of resistance and susceptibility of CD4+ T cells to human immunodeficiency virus (HIV)-gp120 induced anergy.
    Faith A; O'Hehir RE; Malkovsky M; Lamb JR
    Immunology; 1992 Jun; 76(2):177-84. PubMed ID: 1353060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus.
    Layne SP; Merges MJ; Dembo M; Spouge JL; Conley SR; Moore JP; Raina JL; Renz H; Gelderblom HR; Nara PL
    Virology; 1992 Aug; 189(2):695-714. PubMed ID: 1386485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis induction by human immunodeficiency virus type 1 (HIV-1) gp120 peptides.
    Pugliese O; Boirivant M; Viora M
    Viral Immunol; 1997; 10(2):95-102. PubMed ID: 9210283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.